Keywords: Parkinson's Disease, Metabolism
Motivation: N-acetylaspartate (NAA) and creatine (Cr) are two brain metabolites implicated in neuronal functions. The potential role of MRS as in vivo molecular imaging biomarker is controversial.
Goal(s): Quantitative the concentration of NAA and tCr of posterior cingulate gyrus (PCC) and Thalamus (Tha) in Parkinson’s disease patients with (PDCI) and without mild cognitive impairment (PDN).
Approach: Single voxel 1H-MRS technology combined with Lcmodel software were used.
Results: Patients with PDCI showed significantly reduced concentrations of NAA and tCr both in PCC and left Tha regions. Both in PCC and left Tha, the reduction of NAA accompanying with decreasing of tCr.
Impact: Comparison of PCC and Tha MRS profiles across cognitive impairment provides useful information for tracking cognitive decline in PD progress. Cortical (via PCC) and subcortical (via Tha) NAA and tCr are promising biomarkers in characterizing PD cognitive stage deficits.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords